Group 1 - The technology utilizes cells from a leading innovative stem cell therapy company in China, with a core team experienced in cell therapy and related cutting-edge technologies, having published multiple academic papers in top-tier research institutions like Yale and Harvard [2] - The company has established a standardized technical system for process design, critical quality attribute (CQA) control, and QC/QA release processes, achieving international advanced levels in the development and production of various cell therapy products [2] - The company has undertaken multiple national-level research projects, creating a complete technology platform around key aspects of the cell therapy industry chain, including cell separation, purification, large-scale expansion, formulation process development, quality control, and safety evaluation [2] Group 2 - Hainan Diwan Hospital leverages the "pilot and trial" policy advantages of the Boao Lecheng International Medical Tourism Pilot Zone to promote the implementation of this technology, becoming a leading project in clinical application scale and patient acceptance since its approval in February 2025 [4] - The hospital is recognized as a high-end medical institution in the fields of regenerative medicine, gut microbiome, and new biomedicine technologies, collaborating deeply with top national medical resources and establishing strategic partnerships with institutions like Shanghai Ruijin Hospital [4] - The hospital has formed a long-term strategic cooperation mechanism with several academicians from the Chinese Academy of Sciences and the Chinese Academy of Engineering, continuously advancing original technology transformation and clinical application in regenerative medicine and gut microbiome [4] Group 3 - The establishment of the "Boao Lecheng Innovative Orthopedic New Technology Research Institute" aims to integrate national-level authoritative academic resources and gather innovative technologies, clinical experiences, and research results in orthopedics [6] - The stem cell treatment project for knee osteoarthritis (KOA) has gained significant attention and professional support from top orthopedic experts, addressing the challenges of limited drug efficacy and controversial surgical interventions in treating KOA [6] - The hospital plans to continuously introduce safe, effective biomedical innovations with independent intellectual property rights, enhancing the application capabilities of new biomedical technologies and promoting high-quality development in high-end medical and biomedicine industries [6]
海南帝湾医院获批开展干细胞治疗膝骨关节炎转化应用项目
Sou Hu Wang·2026-01-15 07:54